By Jeffry John Aufderheide Media and public relation campaigns literally portray the U.S. FDA as superheroes. For example, the FDA came to the rescue about E. coli tainted spinach, Chinese-made baby formula containing melamine, and even removing salmonella-laced peanut butter from grocery store shelves. Those aforementioned events ought to be the measuring stick for parents […]
No Cancer Vaccine for Boys
By Andrew M. Potts The Pharmaceutical Benefits Advisory Committee (PBAC) has rejected a submission to add the human papillomavirus (HPV) vaccine Gardasil to the Pharmaceutical Benefits Scheme (PBS) for use in males. Gardasil is currently only available on the PBS for girls through the National Immunisation Program (NIP) to combat cervical cancer. Last year, drug […]
Merck Dodges FDA Bullet and Wins Approval for Gardasil Expansion from Health Canada
By Leslie Carol Botha, Vice President Public Relations, SaneVax Inc. PRLog (Press Release) – May 02, 2011 – SANE Vax Inc. is highly disturbed Merck has not taken FDA advice to prove vaccine efficacy in 26 to 45 year old women prior to getting approval from other governments for use in this age group. According […]
Polio Outbreak From Oral Vaccine Identified — And Controlled — In China
ScienceDaily (Aug. 15, 2006) — A 2004 outbreak of polio in China traced back to live attenuated oral polio vaccine (OPV), which is widely used in global eradication efforts, highlights the small but significant risk to eradication posed by the use of OPV at suboptimal rates of coverage. The study, reported in the Sept. 1 […]
Canada Approves Gardasil For Use In Most Women
By Ed Silverman Less than a month after the FDA refused to approve the Gardasil vaccine for preventing HPV in women ages 27 to 45, Health Canada has gone in the other direction and issued an endorsement. Although Canada is a smaller market than the US, the approval is a notable step for Merck, which […]
- « Previous Page
- 1
- …
- 223
- 224
- 225
- 226
- 227
- …
- 313
- Next Page »